Insiders Ascendis Pharma A/S

Equities

ASND

US04351P1012

Real-time Estimate Cboe BZX Other stock markets 18:33:06 09/05/2024 BST			5-day change	1st Jan Change
133.9 ^USD	-0.03%		-4.83%	+6.61%

05-06	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
05-03	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ascendis Pharma A/S Appoints Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer	02-29	CI
TD Bank Announcing "Significant Expansion" of Its Global Financial Institutions Group	12-04	MT
Viatris Projects Lower 2023 Revenue Despite Swinging to Fourth-Quarter Profit	27/02/23	MT
BioAtla President Scott Smith to Leave; Appointed as CEO at Viatris	27/02/23	MT
Viatris names Scott Smith as CEO ahead of planned divestiture of certain businesses	27/02/23	RE
Ascendis Pharma A/S Appoints William Carl Fairey Jr. and Siham Imani as Class I Directors	12/09/22	CI
Ascendis Pharma A/S Announces Management Changes	23/05/22	CI
Ascendis Pharma A/S Announces Resignation of James I. Healy as Independent Member of Board of Directors, Effective from May 30, 2022	02/05/22	CI
Synlogic Names Michael Jensen Finance Chief	03/03/22	MT
Ascendis Pharma A/S Elects Rafa?le Tordjman as A Class II Director	18/11/21	CI
Prime Mining : Appoints New Board Member and Exploration Executive, Provides Update	27/09/21	MT
Insider Trends: Insider 90-Day Selling Trend Prolonged at Paycom Software	14/07/21	MT
Ascendis Pharma A/S Appoints Birgitte Volck as the Senior Vice President & Head of Clinical Development & Medical Affairs, Endocrinology Rare Diseases and Resigns from the Nominating and Corporate Governance Committee of the Company’S Board of Directors and Board of Directors	14/06/21	CI
Ascendis Pharma A/S Announces Michael Wolf Jensen Does Not Stand for Re-Election to Its Board	14/12/20	CI
Ascendis Pharma A/S Appoints Dr. Mark A. Bach as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases	03/11/20	CI
Bayer : Invests in US Immunotherapy Company Triumvira Immunologics	27/08/20	DJ
Ascendis Pharma A/S to Appoint Jesper Høiland as Global Chief Commercial Officer	11/05/20	CI
Ascendis Pharma A/S Elects Lisa Morrison as Class I Director	30/05/19	CI
Ascendis Pharma A/S Appoints Sigurd Okkels as Senior Vice President of Product Development	03/04/19	CI
Ascendis Pharma A/S Establishes Oncology as its Second Independent Therapeutic Area; Appoints Juha Punnonen as Senior Vice President and Head of Oncology	07/01/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Ascendis Pharma A/S

Equities

ASND

US04351P1012

Insiders

Filters